‘Made In China’ Provision Removed From Green Channel Policy
This article was originally published in The Gray Sheet
Executive Summary
The original draft of an accelerated approval policy in China for innovative devices included a condition that a product being considered for the special pathway “is produced in China.” That condition has been removed from the latest draft following pressure from the U.S. government.
You may also be interested in...
Global View: Talking Harmonization And China With Jeffrey Gren
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China.
New China Fast-track Review Allows International Devices Accelerated Approval
China FDA revised its regulation allowing both domestic and foreign device makers to apply for the special review process. However, a murky domestically initiated innovation requirement still worries multinational companies.
Global View: Talking Harmonization And China With Jeffrey Gren
The just-retired Commerce official Jeffrey Gren discusses the impact of globalization on the medical device industry, and the issues the sector is facing in China, in an interview with “The Gray Sheet.” Gren retired from the U.S. Department of Commerce in January after decades of focusing on device and drug trade issues.